Kraft Heinz to remove artificial dyes from products sold in U.S.
Kraft Heinz will remove artificial dyes from its products sold in the U.S. by the end of 2027, the company announced Tuesday. The multinational food company also said it will stop making new products that contain these dyes, effective immediately.
Kraft Heinz, the manufacturer of foods such as Jell-O, Capri Sun and Kool-Aid, said in an online statement that 10% of its products contain the dyes and that it has invested in removing the colors or replacing them with natural colors.
Kraft Heinz replaced artificial dyes in its Kraft Mac & Cheese product in 2016, while some other products, including Heinz Tomato Ketchup, have never had dyes, the company said. Kraft Heinz's announcement comes amid a push from U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. to root out artificial dyes from the nation's food supply and instead replace them with natural dyes.
"The vast majority of our products use natural or no colors, and we've been on a journey to reduce our use of FD&C (Food, Drug & Cosmetic) colors across the remainder of our portfolio," said Pedro Navio, North America president at Kraft Heinz in the company's statement.
Over 200 brands are manufactured by Kraft Heinz, which is headquartered in Chicago, Illinois. CBS MoneyWatch reached out to Kraft Heinz to inquire which products in its portfolio still include artificial dyes but did not immediately hear back.
The push to end synthetic dyes
In April, the U.S. Food and Drug Administration and the HHS asked the food industry to stop using synthetic food dyes.
"For too long, some food producers have been feeding Americans petroleum-based chemicals without their knowledge or consent," Kennedy said at the time.
The agencies, however, have stopped short of introducing an all-out ban — something Kennedy floated as part of his "Make America Healthy Again" platform while on the campaign trail.
The FDA currently allows 36 food color additives, including eight synthetic dyes. The dyes are used heavily in U.S. products, although certain states, including California and West Virginia, have enacted bans to restrict their use.
FDA commissioner Marty Makary said at a news conference in April the agency is working to eliminate synthetic dyes by the end of 2026, although whether that happens will depend on voluntary efforts from the food industry.
Meet the NYC dad who won the Pedro Pascal look-alike contest
Exclusive discounts from CBS Mornings Deals
Can Israel's strikes stop Iran from developing nuclear weapons?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Las Vegas hotel slammed after guest stuck with outrageous bill for a bottle of water
It's not just slot machines that are fleecing people. A Las Vegas hotel is being lambasted mercilessly online after charging nearly $30 for a bottle of water from room minibars. The apparent H20 highway robberies came to light via photos and a fan submission shared by the travel blog A View From the Wing. The unidentified guest had reportedly been staying at the Aria Resort & Casino — one of over 30 MGM resorts — where room rates start at $280 per night. According to the post, an employee had been restocking and cleaning out their room's minibar, which the visitor noted had 'food crammed in the fridge from two guests ago.' The worker informed the visitor that water costs $26, but only told them after the guest had consumed a full bottle, the poster wrote. That constituted more than 10% of the person's total bill of $259, according to a screenshot of their invoice. To make matters worse, the same water reportedly costs just $7.45 at a Starbucks downstairs. While hotel minibars are known for their extortionate markups, some Aria guests noted that the other items in the fridge were not nearly as steep. , shared a photo of a hotel minibar menu showing a Coca-Cola Deluxe that cost $13.75, nearly half as much as the Fiji Water, which set guests back a whopping $24.75. 'Do you think it's fair to pay for the convenience, or this is price gouging?' the traveler spluttered in the caption. Commenters were similarly perplexed over the price tags, with one writing, 'Was just there. I was floored.' 'Vegas is dying so they have to charge a buttload to survive,' declared another, referencing declining tourist numbers at the gambling mecca. 'They depend on the drunk visitors that don't care about their prices at 2 a.m. when they get back to their room,' said a third. A View From the Wing contributor Gary Leff accused Aria of flouting the 'diamonds-water paradox' floated by 'The Wealth of Nations' author Adam Smith, who wrote that water is necessary but cheap, while diamonds are useless for survival but expensive due to their scarcity. 'Aria in Las Vegas proves there really was no paradox after all,' Leff quipped. 'Water in the desert is crucial to survival and incredibly expensive for guests staying there!' He declared that Sin City had 'clearly given up on any idea of hospitality.' 'I would think, though, that a $36.28 per night resort fee (inclusive of tax) might be high enough to offer a single bottle of water as one of its inclusions. I guess not!' Leff griped. 'This is the perfect example of the kind of out of sample cost that makes people feel cheated on a Las Vegas trip, leaving customers with a bad taste in their mouth. And that is dangerous heading into a Las Vegas downturn.'
Fast Company
21 minutes ago
- Fast Company
The role of consumer health in expanding access to care
Healthcare is evolving. Once confined to clinics and in-office appointments—healthcare is now in our homes, routines, and daily choices. The shift towards accessible healthcare solutions, like over-the-counter (OTC) medicines, is empowering people to manage their health proactively. With 81% of adults using OTC medicines for minor ailments, this societal change saves physicians many hours each year, reducing the strain on healthcare systems. Despite increasing consumer interest in self-care, critical health categories like pain management, skin cancer, and more remain undertreated, underdiagnosed, and underpenetrated. The self-care revolution Consumers are increasingly investing in their health. In the U.S. alone, a staggering 82% of consumers consider health and wellness a leading priority in their lives, contributing to a $480 billion market. This clear sign shows that more people are actively taking charge of their well-being today to build a healthier future. Yet, accessibility gaps persist. Science and innovation must bridge this gap—not just through new formulations, but through better awareness, education, and application methods. Consumer-focused companies like ours are working to address this. The power of innovation Despite skin cancer diagnoses outnumbering all other cancers in the U.S., only 13.5% of adults wear sunscreen daily. Our research found that 99% of healthcare providers believe better application and aesthetics would boost sunscreen use. In response, our R&D teams at Neutrogena developed a new mineral formula that overcame these top consumer barriers with more UVA protection and less whitening compared to competitors, all while providing a lightweight, invisible finish. Our goal is to improve consumers' willingness to wear sunscreen regularly, protecting their skin and health. While new innovations create a solution to the problem, education is what empowers consumers to pick it up in the aisle. For example, research shows a need for wider education about sun care in schools, so Neutrogena teamed up with Walgreens and the Melanoma Research Foundation to teach students and families the importance of sunscreen use. Programs like this help people understand how to practice preventative care, and its benefits as one of the most powerful tools in reducing health inequities. Where do we go from here? Consumer health companies can make a difference—whether through smarter skincare solutions, new pain relief technologies, or improved application methods. Here are three ways to do that. 1. Accessibility must be a priority, not an afterthought Despite advancements in OTC medicine, inaccessibility remains widespread. According to the World Health Organization, nearly 2 billion people lack reliable access to essential medications, such as acetaminophen in the pain care category. Beyond availability, consumers are also facing unique barriers based on their needs or stage of life. Despite many pain relief options being in pill form, people are often averse to swallowing pills for a variety of reasons ranging from general dislike to fear of choking. To make pain care accessible to more people, this unique need must be front and center in product development. Our Tylenol teams used this information and philosophy to develop products for several life stages, adding powder packs to make it easier for children to swallow, and a topical pain relief formation for those with skin discomfort Accessibility drove the creation to ensure that more people could get the relief they needed in a way that worked for them. 2. Sustainability is front and center Consumers today want products that not only enhance personal health but also minimize environmental impact. The future of consumer health is one where science works smarter, faster, and more sustainably, ensuring the well-being of people and the planet. As part of Kenvue's approach, we developed an internal assessment tool, the Sustainable Innovation Profiler, which helps our product developers select more sustainable ingredients, packaging, and product formats. Integrating this capability into our innovation process should help us meet the rising expectations of consumers, retailers, and regulators, while building a more resilient and sustainable future and driving brand growth. 3. Collaboration is key to expanding everyday care No single company can solve the accessibility crisis alone. Partnerships between brands, healthcare providers, retailers, and policymakers are essential for meaningful impact. We do this by partnering with dermatologists, pediatricians, and public health organizations to identify care gaps and address misinformation. By meeting consumers wherever they are—aisles, pharmacies, doctor's offices, or online—we empower them to take charge of their health.
Yahoo
24 minutes ago
- Yahoo
Ex-Loretto hospital CFO hit with new charges alleging massive $290 million COVID testing fraud scheme
A former top executive of Loretto Hospital on Chicago's West Side has been charged in a massive $290 million fraud scheme that allegedly used stolen patient data to bill nearly a billion dollars worth of bogus COVID-19 tests for purportedly uninsured patients at the height of the pandemic. The 48-page indictment unsealed in U.S. District Court on Tuesday marked the latest — and largest — fraud scheme involving the small West Side safety-net hospital that became a lighting rod of controversy during the coronavirus pandemic for administering vaccinations to connected insiders and paying millions in contracts to companies with close ties to facility administrators. Anosh Ahmed, who was previously indicted in a related scheme to embezzle $15 million from Loretto itself, was charged in the new 24-count indictment with wire fraud, illegal kickbacks and other financial crimes. Also charged were Mohamed Sirajudeen, 53, an Ahmed associate who operated a clinic called Chicago Polyclinic LLC, as well as Mahmood Sami Khan, 36, and Suhaib Ahmad Chaudhry, 34, both former employees of Anosh Inc., a Houston-area company Ahmed formed after leaving Loretto in 2021. Ahmed, 41, fled to Dubai before he was first charged last year and has not returned, court records show. Over the past year, he's been using a public relations firm to produce news releases calling himself a 'billionaire agripreneur' dedicated to philanthropic causes, including donating millions of pounds of food to the needy in Lebanon. His lawyer, Dan Webb, could not immediately be reached. Chaudhry and Khan were arrested in the Houston area Tuesday and were expected to appear in court there on Wednesday, court records show. Sirajudeen has arranged to surrender through his attorney. It was not clear if any of the three defendants had hired attorneys. According to the indictment, from April 2021 to June 2022, Ahmed and his co-conspirators used laboratories they opened in Illinois and Texas to submit false claims to the Health Resources and Services Administration for COVID testing of specimens 'purportedly collected from uninsured individuals, knowing that such testing had not occurred.' In all, the false claims sought reimbursement for nearly $895 million, of which more than $293 million was actually paid, the indictment stated. To further the scheme, after Ahmed left Loretto Hospital in April 2021, he had a hospital executive identified as Individual F to obtain a spreadsheet containing personal identifiers — including names, dates of birth, gender and addresses — collected from more than 150,000 Loretto patient visits between July 2014 and June 2020, the indictment alleged. Similar personal information was collected from patients who ordered COVID-19 antigen at-home test kits from an internet site run by Khan, as well as individuals who provided it 'for the purpose of receiving further information about COVID-19,' the indictment stated. The indictment alleged Ahmed used a variety of methods to try to conceal the scheme, including by having Individual F create a new email address with Loretto's domain name to 'create the false appearance that Ahmed was working on behalf of (Loretto)' and that the hospital was reporting test results to patients, the indictment alleged. Ahmed also created a number of false and backdated invoices to minimize his involvement with the various labs, communicated in encrypted messaging apps and ordered co-schemers to replace phones and destroy communications and other documents relating to the scheme, the indictment stated. The indictment sought forfeiture in more than $100 million in cash and securities in various accounts controlled by Ahmed, as well as seizure of four luxury properties in Texas, and vehicles including two Rolls-Royces, a Lamborghini Huracan and a Mercedes Benz. The indictment is the latest in a federal investigation initiated after Loretto came under fire for improperly doling out COVID-19 vaccinations soon after the shots became available. In 2021, following reporting by Block Club Chicago and WBEZ, Loretto admitted it had improperly vaccinated workers at Trump Tower in downtown Chicago and had also improperly given shots to Cook County judges at a time when the vaccines were still scarce. Ahmed resigned from his position as chief financial officer in 2021 after the hospital's board voted to terminate him. Last year, Ahmed was charged in a separate embezzlement case along with former Loretto CEO George Miller; Heather Bergdahl, a friend of Ahmed's from Houston whom he hired in 2020 to serve as Loretto's chief transformation officer; and Sameer Suhail, 47, of Chicago, a doctor and medical supply company owner accused of serving as a front for millions of dollars in bogus payments by Loretto for invoices that were never fulfilled. Miller, who left the hospital amid the fallout in 2022, is cooperating and is expected to plead guilty. Suhail is also believed to be living in Dubai, where he traveled before his indictment. Bergdahl, meanwhile, was arrested after boarding a private jet in Houston that was bound for Dubai. She has pleaded not guilty and is awaiting trial. jmeisner@
